相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis
Nipat Chuleerarux et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy
Laura I. Levi et al.
AIDS (2022)
New Perspectives on Antimicrobial Agents: Maribavir
Virginie Halpern-Cohen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx
Tae Gun Kang et al.
NATURE COMMUNICATIONS (2022)
Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis
Caleb P. Skipper et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Moving mycoses up the global agenda
[Anonymous]
LANCET GLOBAL HEALTH (2022)
Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients
Hannah N. Imlay et al.
CLINICAL INFECTIOUS DISEASES (2021)
Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients
Pakpoom Phoompoung et al.
TRANSPLANTATION (2020)
Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa
Caleb Skipper et al.
CLINICAL INFECTIOUS DISEASES (2020)
Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program
Christine Robin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Current Understanding of Cytomegalovirus Reactivation in Critical Illness
Hannah Imlay et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
The Cytomegalovirus Protein Kinase pUL97: Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting
Mirjam Steingruber et al.
MICROORGANISMS (2020)
Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis
Lucia Moreira-Teixeira et al.
NATURE COMMUNICATIONS (2020)
Modulation of innate and adaptive immunity by cytomegaloviruses
Richard Berry et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
Mohamed Zuhair et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
Joshua Rhein et al.
LANCET INFECTIOUS DISEASES (2019)
The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015-2017 (vol 6, ofz419, 2019)
Jayne Ellis et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults
Caleb Skipper et al.
JOURNAL OF FUNGI (2019)
Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort
Sergio Carmona et al.
CLINICAL INFECTIOUS DISEASES (2018)
Murine CMV induces type 1 IFN that impairs differentiation of MDSCs critical for transplantation tolerance
Anil Dangi et al.
BLOOD ADVANCES (2018)
Review of cytomegalovirus coinfection in HIV-infected individuals in Africa
Helene Ladefoged Gronborg et al.
REVIEWS IN MEDICAL VIROLOGY (2017)
Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire
Aaron Christensen-Quick et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2017)
Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection
Mark R. Schleiss et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs
Ko Sato et al.
PLOS ONE (2015)
Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor-Dependent Pathway
Paul S. Redford et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection
Ivan Osokine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance
Leilani Schwarcz et al.
AIDS (2013)
Cytomegalovirus Viremia in Thai HIV-Infected Patients on Antiretroviral Therapy: Prevalence and Associated Mortality
Nicolas Durier et al.
CLINICAL INFECTIOUS DISEASES (2013)
LETERMOVIR Treatment of Human Cytomegalovirus Infection Antiinfective Agent
Priya S. Verghese et al.
DRUGS OF THE FUTURE (2013)
Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited Settings
Kara N. Durski et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis
Joseph N. Jarvis et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Arne B. Brantsaeter et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
M. Estee Toeroek et al.
CLINICAL INFECTIOUS DISEASES (2011)
Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa
Katherine Fielding et al.
PLOS ONE (2011)
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Matthew P. R. Berry et al.
NATURE (2010)
Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007)
Romain Micol et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Prevalence of Persistent and Latent Viruses in Untreated Patients Infected With HIV-1 From Ghana, West Africa
Lara Isobel Compston et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
Andrew A. Adjei et al.
BMC INFECTIOUS DISEASES (2008)
Cytomegalovirus reactivation in critically ill immunocompetent patients
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
JR Deayton et al.
LANCET (2004)
Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy
J Berenguer et al.
CLINICAL INFECTIOUS DISEASES (2002)
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection.
JCLB de Quiros et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
